SEC freezes Nasdaq approval of QBTC Bitcoin options after CME challenge

The U.S. Securities and Exchange Commission has granted CME Group’s petition to review Nasdaq PHLX’s approval to list QBTC, a cash-settled Bitcoin index options product, leaving the earlier staff-level approval suspended while the full Commission considers the case. Public statements are due by Aug. 24, but the agency has set no deadline for a final ruling. The dispute centers on whether a direct option on a Bitcoin price index can trade under securities-market rules or falls exclusively under Commodity Futures Trading Commission oversight because Bitcoin is treated as a non-security commodity. CME argues that Nasdaq would be allowed to offer an economically comparable product to CME’s own Bitcoin derivatives without registering under the commodities framework that governs designated contract markets, swap execution facilities and derivatives clearing. Nasdaq’s proposed contract would be cash-settled and exercisable at expiration, with intraday pricing linked to the CME CF Bitcoin Real Time Index and final settlement based on the New York variant of the CME CF Bitcoin Reference Rate. Each contract would provide reference exposure roughly equal to one Bitcoin. Even if the SEC ultimately upholds the approval, the product would still require CFTC exemptive relief for listing and clearing, as well as Options Clearing Corporation documentation and approval steps before trading could begin. The case has become a broader test of whether securities exchanges can use concurrent SEC-CFTC oversight to enter markets historically reserved for CFTC-regulated commodity derivatives. CME says the SEC staff’s interpretation could extend beyond Bitcoin to products tied to commodities such as gold, oil, corn and wheat that already have securities-market exposure through ETFs.